相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma
Manh-Cuong Vo et al.
EXPERIMENTAL HEMATOLOGY (2017)
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
Manh-Cuong Vo et al.
ONCOTARGET (2017)
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties
Federica Costa et al.
ONCOTARGET (2017)
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
Lien Vandenberk et al.
FRONTIERS IN IMMUNOLOGY (2016)
The Varieties of Immunological Experience; Of Pathogens, Stress, and Dendritic Cells
Bali Pulendran
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
Thanh-Nhan Nguyen-Pham et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Expanding role of lenalidomide in hematologic malignancies
Nilanjan Ghosh et al.
CANCER MANAGEMENT AND RESEARCH (2015)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
TNF and MAP kinase signalling pathways
Guadalupe Sabio et al.
SEMINARS IN IMMUNOLOGY (2014)
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
Joshua Richter et al.
BLOOD (2013)
Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells
Beatriz Abos-Gracia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells
Kinga K. Hosszu et al.
BLOOD (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Ubiquitin-mediated Regulation of CD86 Protein Expression by the Ubiquitin Ligase Membrane-associated RING-CH-1 (MARCH1)
Kathleen Corcoran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation
Lina E. Tze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo
Zhengzi Qian et al.
LEUKEMIA RESEARCH (2011)
Microbial manipulation of receptor crosstalk in innate immunity
George Hajishengallis et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Lenalidomide mode of action: linking bench and clinical findings
Faith Davies et al.
BLOOD REVIEWS (2010)
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
Christine Galustian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
I. Breitkreutz et al.
LEUKEMIA (2008)
MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation
Aude De Gassart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells
Dominique Verhelle et al.
CANCER RESEARCH (2007)
PPARγ controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells
Istvan Szatmari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications
David H. Chang et al.
BLOOD (2006)
Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: Involvement of activation of extracellular signal-regulated protein kinase
CQ Xia et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Potential new therapeutics for Waldenstrom's macroglobulinemia
JB Zeldis et al.
SEMINARS IN ONCOLOGY (2003)
Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro
PAJ Haslett et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
K Dredge et al.
BRITISH JOURNAL OF CANCER (2002)
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
PG Richardson et al.
BLOOD (2002)
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
N Mitsiades et al.
BLOOD (2002)
DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-β, and anti-inflammatory agents
M Relloso et al.
JOURNAL OF IMMUNOLOGY (2002)
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
D Gupta et al.
LEUKEMIA (2001)
分享论文
